Spiros Jamas - Jan 1, 2022 Form 3/A - Amendment Insider Report for Entera Bio Ltd. (ENTX)

Role
Chief Executive Officer
Signature
/s/ Dana Yaacov-Garbeli, Attorney-in-fact
Stock symbol
ENTX
Transactions as of
Jan 1, 2022
Transactions value $
$0
Form type
3/A - Amendment
Date filed
1/24/2022, 03:13 PM
Date Of Original Report
Jan 20, 2022
Next filing
Jan 24, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ENTX Stock Option (right to buy) Jan 1, 2022 Ordinary Shares, par value NIS 0.0000769 per share 1.31M $1.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 3 amendment is being filled to correct the original Form 3 filed on January 20, 2022. The original Form 3 inadvertently marked the Reporting Person as a director of Entera Bio Ltd. The Reporting Person is only an officer of Entera Bio Ltd. as reflected herein.

Remarks:

See Exhibit 24.1 - Power of Attorney